Literature DB >> 29777014

A Case of Monoclonal Gammopathy of Renal Significance.

Jonathan J Hogan1.   

Abstract

Entities:  

Keywords:  Monoclonal Gammopathy of Undetermined Significance; Paraproteinemias; glomerular disease; glomerulonephritis; kidney; multiple myeloma

Mesh：

Year:  2018        PMID： 29777014      PMCID： PMC5989672          DOI： 10.2215/CJN.00470118

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  9 in total

1.  Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft.

Authors:  Samih H Nasr; Sanjeev Sethi; Lynn D Cornell; Mary E Fidler; Mark Boelkins; Fernando C Fervenza; Fernando G Cosio; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

2.  Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits.

Authors:  Gauri Bhutani; Samih H Nasr; Samar M Said; Sanjeev Sethi; Fernando C Fervenza; William G Morice; Paul J Kurtin; Francis K Buadi; David Dingli; Angela Dispenzieri; Morie A Gertz; Martha Q Lacy; Prashant Kapoor; Shaji Kumar; Robert A Kyle; S Vincent Rajkumar; Nelson Leung
Journal:  Mayo Clin Proc       Date:  2015-05       Impact factor: 7.616

3.  Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease.

Authors:  Camille Cohen; Bruno Royer; Vincent Javaugue; Raphael Szalat; Khalil El Karoui; Alexis Caulier; Bertrand Knebelmann; Arnaud Jaccard; Sylvie Chevret; Guy Touchard; Jean-Paul Fermand; Bertrand Arnulf; Frank Bridoux
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

4.  A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits.

Authors:  Ramnika Gumber; Jordana B Cohen; Matthew B Palmer; Sidney M Kobrin; Dan T Vogl; Alan G Wasserstein; Sunita D Nasta; Melissa B Bleicher; Roy D Bloom; Laura Dember; Adam Cohen; Brendan M Weiss; Jonathan J Hogan
Journal:  Kidney Int       Date:  2018-05-11       Impact factor: 10.612

5.  Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.

Authors:  Sophie Chauvet; Véronique Frémeaux-Bacchi; Florent Petitprez; Alexandre Karras; Laurent Daniel; Stéphane Burtey; Gabriel Choukroun; Yahsou Delmas; Dominique Guerrot; Arnaud François; Moglie Le Quintrec; Vincent Javaugue; David Ribes; Laurence Vrigneaud; Bertrand Arnulf; Jean Michel Goujon; Pierre Ronco; Guy Touchard; Frank Bridoux
Journal:  Blood       Date:  2017-01-09       Impact factor: 22.113

Review 6.  Bridging the Divide: An Onco-Nephrologic Approach to the Monoclonal Gammopathies of Renal Significance.

Authors:  Jonathan J Hogan; Brendan M Weiss
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-14       Impact factor: 8.237

Review 7.  Diagnosis of monoclonal gammopathy of renal significance.

Authors:  Frank Bridoux; Nelson Leung; Colin A Hutchison; Guy Touchard; Sanjeev Sethi; Jean-Paul Fermand; Maria M Picken; Guillermo A Herrera; Efstathios Kastritis; Giampaolo Merlini; Murielle Roussel; Fernando C Fervenza; Angela Dispenzieri; Robert A Kyle; Samih H Nasr
Journal:  Kidney Int       Date:  2015-01-21       Impact factor: 10.612

8.  Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.

Authors:  Samih H Nasr; Glen S Markowitz; M Barry Stokes; Surya V Seshan; Elsa Valderrama; Gerald B Appel; Pierre Aucouturier; Vivette D D'Agati
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

9.  Proliferative glomerulonephritis with monoclonal IgG deposits.

Authors:  Samih H Nasr; Anjali Satoskar; Glen S Markowitz; Anthony M Valeri; Gerald B Appel; Michael B Stokes; Tibor Nadasdy; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2009-05-21       Impact factor: 10.121
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.